Frank Vinluan

Frank Vinluan is the North Carolina Bureau Chief for MedCity News.

Follow Frank Vinluan:


Experimental lupus therapy from Argos in partnering talks after strong phase 1

Experimental lupus therapy from Argos in partnering talks after strong phase 1

June 8, 2012 1:24 pm by | 1 Comments

  The experimental lupus treatment being developed by Argos Therapeutics is showing promise in early stage clinical trials, but the questions remain whether it’s enough progress to attract interest from…


Less than 1% of HGSI shares tendered for sale; GSK extends $2.6B offer

Less than 1% of HGSI shares tendered for sale; GSK extends $2.6B offer

June 8, 2012 10:47 am by | 0 Comments

GlaxoSmithKline‘s (NYSE:GSK) $2.6 billion offer to buy Human Genome Sciences (NASDAQ:HGSI) has enticed holders of 474,029 shares of the Maryland biotechnology company to tender their stock for the sale. The…



CHTP cuts executive pay 25 percent, suspends bonuses to pay for trials

CHTP cuts executive pay 25 percent, suspends bonuses to pay for trials

June 7, 2012 5:47 pm by | 0 Comments

Drug developers typically turn to investors to finance clinical work on drug candidates. Chelsea Therapeutics (NASDAQ:CHTP) executives and directors are slashing their own paychecks to help pay for that work…


Corneal transplant’s next frontier? OSI eyes regenerative medicine

Corneal transplant’s next frontier? OSI eyes regenerative medicine

June 7, 2012 12:31 pm by | 0 Comments

Ocular Systems Inc. is working to bring medical innovation to an eye surgery that has not changed all that much in 100 years. CEO Jerry Barker founded OSI to prepare…


GSK gets FDA approval on Horizant to treat post-shingles pain

GSK gets FDA approval on Horizant to treat post-shingles pain

June 7, 2012 10:16 am by | 0 Comments

GlaxoSmithKline‘s (NYSE:GSK) restless leg syndrome drug Horizant has received U.S. approval for the new indication of treating pain following shingles. The condition, called postherpetic neuralgia (PHN), is a nerve pain…


Healthcare social media will level the information playing field for ‘prosumers’

Healthcare social media will level the information playing field for ‘prosumers’

June 6, 2012 2:53 pm by | 0 Comments

Social media should allow you, the patient, to ultimately have access to the same information that your doctor does. That’s how David E. Williams sees things. The co-founder of biopharmaceutical…


V.P. Biden at Wake Forest Biotech Place: ‘We have to create new industries’

V.P. Biden at Wake Forest Biotech Place: ‘We have to create new industries’

June 6, 2012 2:17 pm by | 0 Comments

Vice President Joe Biden stood today where R.J. Reynolds Tobacco shop workers once labored and evoked the image of that past economy as a bridge to a new one. Biden…



Surgical sealant firm HyperBranch raises $1.7M after getting CE Mark

Surgical sealant firm HyperBranch raises $1.7M after getting CE Mark

June 6, 2012 10:19 am by | 0 Comments

Wound and surgical sealant company HyperBranch Medical Technology, moving to commercialize a new sealant technology in Europe and secure regulatory clearance in the United States, has raised $1.7 million in…


Quintiles tops investigator recruiting survey but pharmas are ‘dissatisfied outsourcers’

Quintiles tops investigator recruiting survey but pharmas are ‘dissatisfied outsourcers’

June 5, 2012 12:45 pm by | 0 Comments

It’s no secret pharmaceutical companies are outsourcing more and more work to clinical research organizations. But when it comes to recruiting doctors to run the studies, they’re not happy at…


CRO Inclinix merges with clinical trials site operator PMG Research

CRO Inclinix merges with clinical trials site operator PMG Research

June 4, 2012 5:15 pm by | 0 Comments

Clinical research organization Inclinix is merging with PMG Research in the latest merger and acquisition deal to hit the CRO space. Inclinix provides clinical trial recruitment services for pharmaceutical, biotechnology…


A surprising reason why some newborns test positive for marijuana

A surprising reason why some newborns test positive for marijuana

June 4, 2012 2:48 pm by | 10 Comments

Some newborns are testing positive for marijuana exposure and the reason why could surprise you. Soap and hand wash products, including products commonly used in hospital nurseries, can interfere with…


Targacept CEO deBethizy resigns from the N.C. biotech

Targacept CEO deBethizy resigns from the N.C. biotech

June 4, 2012 12:17 pm by | 0 Comments

Targacept (NASDAQ:TRGT), already in the midst of a corporate restructuring, must now also search for a new CEO. Don deBethizy is resigning from his positions as CEO and chairman of…


LabCorp builds up specialty testing unit with $241M MEDTOX acquisition

LabCorp builds up specialty testing unit with $241M MEDTOX acquisition

June 4, 2012 11:10 am by | 0 Comments

LabCorp (NYSE:LH) is set to acquire toxicology testing company MEDTOX Scientific (NASDAQ:MTOX) for $241 million as the laboratory testing and diagnostics firm builds out its specialty testing offerings. The definitive…


GSK plans drug applications for two new melanoma treatments

GSK plans drug applications for two new melanoma treatments

June 4, 2012 6:00 am by | 0 Comments

Melanoma GlaxoSmithKline (NYSE:GSK) is readying regulatory submissions for two melanoma treatments based on successful phase 3 clinical trial results of the experimental cancer drugs. GSK is presenting the clinical trial…


A review of the week’s stories about GSK’s attempt to buy HGSI

A review of the week’s stories about GSK’s attempt to buy HGSI

June 1, 2012 6:48 pm by | 0 Comments

Human Genome Sciences formally rejects GlaxoSmithKline’s hostile takeover bid. Read more, stories about the contentious standoff.